Sialylation of lacto-N-neotetraose (LNnT) extending from heptose I (HepI) of 23 gonococcal lipooligosaccharide (LOS) contributes to pathogenesis. Previously, 24 gonococcal LOS sialyltransterase (Lst) was shown to sialylate LOS in Triton X-100 25 extracts of strain 15253, which expresses lactose from both HepI and HepII, the minimal 26 structure required for mAb 2C7 binding. Ongoing work has shown that growth of 15253 27 in cytidine monophospho-N-acetylneuraminic acid (CMP-Neu5Ac)-containing media 28 enables binding to CD33/Siglec-3, a cell surface receptor that binds sialic acid, 29 suggesting that lactose termini on LOS of intact gonococci can be sialylated. Neu5Ac 30 was detected on LOSs of strains 15253 and a MS11 mutant with only lactose from HepI 31 and HepII by mass spectrometry; deleting HepII lactose rendered Neu5Ac undetectable.
Introduction 45
Gonorrhea affects about 78 million people annually worldwide (1); almost 46 470,000 of these are reported in the U.S. Multidrug-resistant gonorrhea has been 47 advantage to subvert host immunity (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) , by mimicking host sialic acid-based "self- is expressed by ~95% of clinical isolates of N. gonorrhoeae (42) , which suggests a key 73 role in virulence. Isogenic mutant strains that lack lgtG show decreased virulence in the 74 mouse vaginal colonization model of gonorrhea (43) . Why HepII lactose promotes 75 gonococcal virulence remains unclear. In recent work, we noted that growth of a 76 gonococcal strain called 15253 that expresses lactose simultaneously from HepI and 77 HepII (44) was capable of binding to Siglec-3 when grown in CMP-Neu5Ac-containing 78 media (45). Siglec-3 binds exclusively to sialyoglycans (46, 47) . These data suggested 79 that lactose expressed by N. gonorrhoeae LOS could also be sialylated. This study 80 describes sialylation of gonococcal LOS lactose termini and elucidates its function in 81 complement evasion and virulence. 82 83 84 these two mutant strains to sialylate their LOSs. 138 We next examined the effects of sialylation on complement activation on six 139 MS11 LOS mutants (Fig. 5) . The sialylatable 3-Hex and 4-Hex strains served as 140 controls for Neu5Ac-mediated complement inhibition. Growth in media containing Neu5Ac decreased C3 deposition all tested strains. Similar to 15253, sialylation of 142 MS11 2-Hex/G+ also inhibited C3 deposition. In contrast to 15253/G-, we noted a 143 reproducible decrease in C3 deposition on the 2-Hex/G-mutant, suggesting that 144 Neu5Ac was also added to the LOS of this strain. The degree of inhibition seen with 145 sialylation of MS11 2-Hex/G-(a 4.1-fold decrease compared to the unsialylated parent, 146 and 7.3-fold above baseline conjugate control levels) was less than that seen with 147 complement inhibition upon sialylation of MS11 2-Hex/G+ (a 21-fold decrease 148 compared to unsialylated 2-Hex/G+, and only 3-fold greater fluorescence compared to 149 the baseline conjugate control). This amount of LOS sialylation of MS11 2-Hex/G-LOS, 150 although functional, was too small to be appreciated by changes in mobility on a Tricine 151 gel or by MS analysis. 152 To discern the sialic acid linkage to HepII substituted lactose we examined the 153 effect of α2-3-linkage-specific neuraminidase on mouse C3 deposition (Fig. 6) . 154 Sialylated 2-Hex/G+ and the corresponding wild-type strain 15253 that possessed the 155 same pattern of Hep I and Hep II hexose substitutions, failed to show increased C3 156 deposition after treatment with recombinant α2-3-specific sialidase followed by 157 incubation with 15% normal mouse serum; resistance to α2-3-sialidase suggests an α2-158 6 linkage. Gal seen in a mutant strain selected under pyocin pressure called JW31R, abrogates 178 mAb 2C7 binding (53). We therefore asked whether sialylation of HepII lactose affected 179 mAb 2C7 binding and function. While sialylation of 15253 did not affect mAb 2C7 (42). We examined a collection of minimally (≤3) passaged isolates 202 cultured from the female contacts of men with gonorrhea who were referred to a STD 203 clinic in Nanjing, China, for expression of the 2C7 LOS epitope by whole cell ELISA. We 204 also examined isolates for their ability to bind to mAb L8 (recognizes an epitope defined We next assessed the ability of mAb 2C7 to mediate complement-dependent 211 bactericidal activity against the first 62 of 75 isolates collected from men with urethritis in 212 a Nanjing (China) study of gonococcal transmission from men to women. Because 213 some of the strains were sensitive to killing by 16.7% pooled normal human serum 214 (NHS) that was used as the complement source, all isolates were grown in media 215 containing 2 µg/ml CMP-Neu5Ac to render them fully serum resistant (>100% survival).
216
All (100%) of isolates were killed >50% in the presence of 5 µg/ml of mAb 2C7 and 217 NHS. This included two of four isolates that bound very low levels of mAb 2C7 by ELISA 218 (OD 450nm between 0.065 and 0.090). Further, serum bactericidal activity correlated with 219 levels of mAb 2C7 binding ( Fig. 10C ). are not aware of any naturally occurring gonococcal isolate that lacks lgtG. We have 263 shown previously that a lgtG deletion mutant of N. gonorrhoeae FA1090 was less 264 virulent than its wild-type parent (43). Lam and Gray-Owen showed that serial passage 265 of N. gonorrhoeae in mice resulted an increased fraction of mice infected with each 266 subpassage and in a reproducible selection of variants with lgtG 'on', providing further 267 strong evidence of the importance of HepII lactose expression in vivo (65). 268 We noted that MS11 2-Hex/G-inhibited mouse complement when grown in 269 CMP-Neu5Ac. The amount of Neu5Ac incorporation onto HepI lactose in this mutant 270 was likely too small to be detected by shifts on SDS-PAGE or by MS analysis, but was 271 nevertheless sufficient for functional activity, limited as it was. In contrast, 15253/G-, 272 which also expresses only lactose from HepI, did not inhibit mouse C3 deposition when 273 grown in CMP-Neu5Ac-containing media, suggesting that the extent and influence of 274 HepI lactose sialylation on function may differ across strains. Whether a difference in 275 HepI lactose sialylation exists between the two strains is unclear despite differences in 276 function, but could relate to differences in Lst sequence and/or levels of Lst activity. 
285
Linkage of Neu5Ac is a key determinant of its ability to interact with the C-286 terminus of FH. Blaum and colleagues showed that the interaction between sialic acid 287 and FH domain 20 is restricted only to α2-3-linked Neu5Ac; α2-6or α2-8-linked 288 Neu5Ac do not interact with FH (67). The Neu5Ac-lactose bond is resistant to α2-3 289 specific sialidase, suggesting an α2-6 linkage. In accordance with the findings of Blaum 290 et al, sialylation of HepII lactosepresumably through an α2-6 linkagedid not 291 increase FH binding to N. gonorrhoeae. We acknowledge that further structural 292 characterization is necessary to confirm the nature of the Neu5Ac-lactose linkage. How from whole blood that was clotted at 25 °C for 30 min followed by centrifugation at 1500 336 g for 20 min at 4 °C. Serum from 10 donors was pooled, aliquoted and stored at -80 °C. ranging from 0 to 100 µg/ml in half-log 10 increments; susceptibility to mAb 2C7 (5 µg/ml) 377 was determined by serum bactericidal assay as described previously (72) given subcutaneously on each of three days; −2, 0 and +2 days (before, the day of and 419 after inoculation) to prolong the estrus phase of the reproductive cycle and promote 420 susceptibility to Ng infection. Antibiotics (vancomycin, colistin, neomycin, trimethoprim 421 and streptomycin (VCNTS)) ineffective against N. gonorrhoeae were also used to 422 reduce competitive microflora (7). Mice (n=10/group) were infected on Day 0 with either 423 strain 15253, 15253/G-or 15253 Δlst (inoculum specified for each experiment).
424
Vaginas were swabbed daily and plated on chocolate agar containing VCNTS to 425 enumerate N. gonorrhoeae CFUs. The efficacy of mAb 2C7 in vivo against 15253 was 426 performed in wild-type BALB/c mice (Jackson Laboratories) as described previously.
427
Mice were treated with mAb 2C7 or control mouse IgG3 intraperitoneally, 10 µg twice a 428 day on days -2, -1 (prior to) and 0 (the day of infection with strain 15253 and daily 429 vaginal CFU enumeration was carried out as described above. shading of the text boxes that contain the numbers) correspond to that of the 772 histograms). X-axis, fluorescence (log 10 scale); Y-axis, counts. One representative 773 experiment of at least two reproducible repeats is shown. Isogenic MS11 mutants that express predominantly lactose (2-Hex), PK structure (3-777 Hex) or LNnT (4-Hex) from HepI, with (G+) or without (G-) lactose from HepII, were 778 grown in the absence or presence of CMP-Neu5Ac (25 µg/ml) and were incubated with 779 15% normal mouse serum for 20 min at 37 °C. Mouse C3 deposited on the bacterial 780 surface was measured by flow cytometry. C3 deposited on bacteria grown in the 781 presence or absence of CMP-Neu5Ac is shown by the grey shaded areas and solid 782 black lines, respectively. Controls (no serum added) are shown by the broken lines.
783
Numbers alongside histograms represent median fluorescence intensity (the border or 784 shading of the text boxes that contain the numbers) correspond to that of the 785 histograms). X-axis, fluorescence (log 10 scale); Y-axis, counts. One representative 786 experiment of at least two reproducible repeats is shown. 
